These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12635473)
41. [Risks of infection related to venous catheterization and an attempt at estimating its financial cost]. Herman B; Wolff MA; Pean Y; Gertner J; Millet H Agressologie; 1985 Feb; 26(2):197-202. PubMed ID: 4051128 [No Abstract] [Full Text] [Related]
42. Some facts about ICU costs. Internist; 1982 Oct; 23(8):8. PubMed ID: 10258710 [No Abstract] [Full Text] [Related]
43. [Economic indicators in intensive care units]. Bárcenas O; Yate D; Hernández HP; Morales R Rev Cubana Enferm; 1986; 2(2):176-82. PubMed ID: 3649840 [No Abstract] [Full Text] [Related]
45. [New treatments of severe sepsis. A scientific, economic, and ethical dilemma]. Torrabadella de Reynoso P; Salgado Remigio A Med Clin (Barc); 1999 Jun; 113(1):18-9. PubMed ID: 10422072 [No Abstract] [Full Text] [Related]
47. Pharmacoeconomic implications of new therapies in sepsis. Wood KA; Angus DC Pharmacoeconomics; 2004; 22(14):895-906. PubMed ID: 15362927 [TBL] [Abstract][Full Text] [Related]
48. What are the challenges of translating positive trial results in severe sepsis into clinical practice? A media roundtable debate, 18 March 2002, Brussels, Belgium. Ball J Crit Care; 2002 Jun; 6(3):271-4. PubMed ID: 12133192 [TBL] [Abstract][Full Text] [Related]
49. [Sepsis in adult patients - definitions, epidemiology and economic aspects]. Moerer O; Quintel M Internist (Berl); 2009 Jul; 50(7):788, 790-4, 796-8. PubMed ID: 19436977 [TBL] [Abstract][Full Text] [Related]
51. [Sepsis therapy -- how effective are the therapy strategies?]. Hanisch E Chirurg; 2008 Sep; 79(9):877. PubMed ID: 18682905 [No Abstract] [Full Text] [Related]
52. Evaluating the clinical and financial impact of severe sepsis with Medicare or other administrative hospital data. Ernst FR; Malatestinic WN; Linde-Zwirble WT Am J Health Syst Pharm; 2006 Mar; 63(6):575-81. PubMed ID: 16522894 [No Abstract] [Full Text] [Related]
53. Crisis and challenge. Downs JB Crit Care Med; 1984 Oct; 12(10):843-5. PubMed ID: 6435954 [No Abstract] [Full Text] [Related]
54. Intensive care units: they save lives, but physicians argue whether their high cost justifies use. Gapen P Am Med News; 1983 Apr; 26(14):7-8. PubMed ID: 10309933 [No Abstract] [Full Text] [Related]
55. Hospital Costs Associated with Sepsis Compared with Other Medical Conditions. Danna DM Crit Care Nurs Clin North Am; 2018 Sep; 30(3):389-398. PubMed ID: 30098742 [TBL] [Abstract][Full Text] [Related]
56. The high cost of acute health care: a review of escalating costs and limitations of such exposure in intensive care units. Spivack D Am Rev Respir Dis; 1988 Feb; 137(2):493. PubMed ID: 3341640 [No Abstract] [Full Text] [Related]
59. Performance Requirements to Achieve Cost-Effectiveness of Point-of-Care Tests for Sepsis Among Patients with Febrile Illness in Low-Resource Settings. Penno EC; Crump JA; Baird SJ Am J Trop Med Hyg; 2015 Oct; 93(4):841-9. PubMed ID: 26195467 [TBL] [Abstract][Full Text] [Related]
60. Sepsis in Africa: practical steps to stem the tide. Otu A; Elston J; Nsutebu E Pan Afr Med J; 2015; 21():323. PubMed ID: 26587170 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]